Pharmaceutical Technology
MARCH 30, 2023
Table 1: Medical product (drugs, devices, and diagnostics) safety budget, 2023 vs. 2024 Source: FDA; GlobalData © GlobalData Whether the proposal passes, and with what alterations, will depend on US Congress. This is made up of $2.1bn in direct funding and $2.4bn in user fees.
The FDA Law Blog
APRIL 21, 2024
Post-AIA, and a later change to the law to account for controlled substance FDA application approvals, the PTE statute at 35 U.S.C. § Accordingly, had Taiho marketed the product with labeling containing those errors, that labeling would have been false. Patent Nos. sections 331(a) and 352. sections 331(a) and 352.(a)(l),
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
MARCH 1, 2024
But determining whether someone needs it is challenging, and because it’s a controlled substance, getting a prescription can be, too. But that’s an off-label use, and while it might help to quell overthinking momentarily, the boost in norepinephrine could exacerbate anxiety symptoms. Do you need an Adderall prescription?
The Checkup by Singlecare
MAY 5, 2024
Strattera is occasionally prescribed off-label for cataplexy and orthostatic hypotension. Condition Strattera Vyvanse ADHD Yes Yes Orthostatic hypotension Off-label No Cataplexy Off-label No Binge eating disorder No Yes Is Strattera or Vyvanse more effective? on the label.
The Checkup by Singlecare
APRIL 2, 2024
RELATED: Overweight and obesity statistics 2024 Where can I get phentermine? Although phentermine is FDA-approved for short-term use, many healthcare professionals will prescribe it off-label for longer-term use. It’s considered a Schedule IV controlled substance , which means that it has the potential to be abused.
The FDA Law Blog
JANUARY 18, 2024
Houck — In August 2023 the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. HHS forwards FDA’s analysis and recommendation to DEA.
The FDA Law Blog
MAY 5, 2024
Houck — The Associated Press reported on Tuesday following confirmation by five anonymous individuals with knowledge that the Drug Enforcement Administration (“DEA”) is moving to reschedule marijuana from schedule I to the less stringently controlled schedule III. treaty obligations in rescheduling. 21 U.S.C. § 812(b)(1).
Expert insights. Personalized for you.
59 
Let's personalize your content